Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Liver Regeneration

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

Tissue Renewal without Stem Cells

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Defining the safety and efficacy of liver-directed AAV gene therapy using a human liver tissue-equivalent platform.

Molecular therapy. Advances·2026

Same author

Sickle Cell Disease: Historical Overview and Current Therapies.

Prenatal diagnosis·2026

Same author

Evaluation of Maternal Safety Following Prenatal Cell and Gene Therapy for Hemophilia A.

Prenatal diagnosis·2026

Same author

In Utero HSC Transplantation for Sickle Cell Disease: A Potential Therapeutic Approach That Overcomes Complications of Current Therapies.

Prenatal diagnosis·2026

Same author

Transplanted gene-modified placental cells boost FVIII activity in pediatric sheep without eliciting immunity, toxicity, or adverse events.

Frontiers in immunology·2026

Same author

Recent advancements in tissue dissociation techniques for cell manufacturing single-cell analysis and downstream processing.

Stem cells translational medicine·2025

Search research articles

Related Experiment Video

Updated: Jun 13, 2026

Isolation of CD133+ Liver Stem Cells for Clonal Expansion

Isolation of CD133+ Liver Stem Cells for Clonal Expansion

Published on: October 10, 2011

Bone marrow stem cells and liver regeneration.

Graça Almeida-Porada¹, Esmail D Zanjani, Christopher D Porada

¹Department of Animal Biotechnology, University of Nevada, Reno, Reno, NV 89557-0104, USA. galmeida@cabnr.unr.edu

Experimental Hematology

|April 27, 2010

Summary

Cell therapy offers a less invasive alternative to liver transplantation for hepatic diseases. Bone marrow-derived stem cells show promise for liver repopulation and regeneration.

More Related Videos

Isolation and Enrichment of Liver Progenitor Subsets Identified by a Novel Surface Marker Combination

Isolation and Enrichment of Liver Progenitor Subsets Identified by a Novel Surface Marker Combination

Published on: February 18, 2017

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Related Experiment Videos

Last Updated: Jun 13, 2026

Isolation of CD133+ Liver Stem Cells for Clonal Expansion

Isolation of CD133+ Liver Stem Cells for Clonal Expansion

Published on: October 10, 2011

Isolation and Enrichment of Liver Progenitor Subsets Identified by a Novel Surface Marker Combination

Isolation and Enrichment of Liver Progenitor Subsets Identified by a Novel Surface Marker Combination

Published on: February 18, 2017

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Area of Science:

Hepatology
Regenerative Medicine
Stem Cell Biology

Background:

Liver transplantation is currently the only definitive treatment for end-stage liver disease.
Cell therapy presents a promising alternative, offering advantages like reduced invasiveness and immunogenicity.
Autologous cell sources can potentially be utilized, minimizing rejection risks.

Purpose of the Study:

To explore the potential of stem/progenitor cells for liver repopulation and regeneration.
To evaluate the suitability of various bone marrow-derived stem cell populations for hepatic repair.
To summarize the characteristics that make stem cells ideal candidates for treating liver diseases.

Main Methods:

Review of existing literature on stem cell therapy for liver diseases.
Analysis of stem cell properties relevant to liver repopulation (e.g., isolation, expansion, genetic modification).
Evaluation of hematopoietic, mesenchymal, and endothelial progenitor cells for hepatic differentiation potential.

Main Results:

Bone marrow-derived stem cells possess key characteristics for liver regeneration, including ease of isolation and in vitro expansion.
These cells demonstrate susceptibility to genetic modification for correcting defects.
Hematopoietic, mesenchymal, and endothelial progenitor cells are identified as ideal candidates for liver regenerative therapies.

Conclusions:

Stem cell therapy holds significant potential to treat hepatic diseases, potentially reducing the need for liver transplantation.
Bone marrow-derived stem cells offer a viable and advantageous approach to liver regeneration.
Further research into these cell populations could lead to novel therapeutic strategies for liver damage and disease.